# US 2025/0082474 A1 · Shaped tissue graft and process to maintain properties

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082474 A1
- Document ID: US20250082474A1
- Status: Published application
- Kind: A1
- Application number: 18/729,386
- Filed: 2023-01-19
- Published: 2025-03-13
- Earliest claimed: 2022-01-19
- Applicants: Restoration Biologics LLC
- Inventors: Suzanne M. TABBAA; William D. BUGBEE; Farshid GUILAK
- Web page: https://patentgrep.com/patent/US20250082474A1

## CPC

- A61F 2/28: Bones
- A61F 2/30942: {for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques}
- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61F 2/4644: {Preparation of bone graft, bone plugs or bone dowels, e.g. grinding or milling bone material (bone material A61F2/28; disintegrating or milling devices B02C)}
- A61B 17/3203: Fluid jet cutting instruments
- A61F 2002/2835: {Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material}
- A61F 2002/30764: {Cartilage harvest sites}
- A61F 2002/30948: {using computerized tomography, i.e. CT scans}
- A61F 2002/30952: {using CAD-CAM techniques or NC-techniques}
- A61F 2002/3096: {trimmed or cut to a customised size}
- A61F 2002/30976: {using hydrojet}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A patient-specific tissue graft and a method of forming the graft is disclosed. A 3D image of a patient's targeted implant site and surrounding anatomy is obtained to note the boundary of the implant site. A 3D model of the graft is formed by utilizing the boundary of the implant site, a surface curvature, extrapolated from the patient's target implant site surrounding anatomy, and a depth, defined by a plane parallel to a plane normal to a point of curvature at the surface. Donor tissue is chosen that has a location with a close approximation to the 3D model of the graft. The donor tissue is visualized to determine a cutting path to shape or modify the architecture of the tissue. A cutting path is determined with imaging technology and computational methods. The graft is cut out of the donor tissue utilizing a fluid cutting process.

## Claims

### Claim 1

A customized tissue graft for repair of a tissue defect, said tissue graft comprising:
a tissue matrix having tissue with a boundary surface, formed through a fluid cutting process, wherein the cutting process employs a fluid formed of a physiological buffered solution and the tissue maintains a native structure and/or viability at the boundary surface.

### Claim 2 (depends on 1)

The tissue graft of claim 1, wherein the graft is in a cylindrical, oblong, rectangular, core, particulate, or irregular form.

### Claim 3 (depends on 1)

The tissue graft of claim 1, wherein the tissue matrix is in particulate form with maintained tissue viability and/or native architecture particulate and is mixed with hydrogels, synthetic or natural materials, polymers, to form the tissue matrix.

### Claim 4 (depends on 1)

The tissue graft of claim 1, wherein the tissue comprises soft and/or hard tissue sourced from a recipient or patient with the tissue defect or from donors.

### Claim 5 (depends on 4)

The tissue graft of claim 4, wherein the tissue comprises musculoskeletal, neural, dermal, cardiovascular, ocular, nasal, costal, adipose, systems, or any tissue or organ type of a donor or autologous tissue.

### Claim 6 (depends on 1)

The tissue graft of claim 1, wherein the tissue is osteochondral tissue with a cartilaginous layer and a bone portion, wherein a boundary of the graft maintains a native matrix and/or viability of the tissue through use of a fluid cutting process.

### Claim 7 (depends on 6)

The tissue graft of claim 6, wherein the bone portion includes a rounded or angled surface edge to aide in implantation.

### Claim 8 (depends on 6)

The tissue graft of claim 6, wherein the cartilaginous layer has a thickness of at least 0.050 mm and wherein the bone portion has a thickness of at least 0.010 mm.

### Claim 9 (depends on 1)

The tissue graft of claim 1 wherein the cutting process further employs a particulate abrasive additive involving biocompatible materials.

### Claim 10 (depends on 6)

The tissue graft of claim 6, wherein the bone portion contains additional tissue removal to allow shape manipulation.

### Claim 11 (depends on 1)

The tissue graft of claim 1, wherein the tissue matrix includes conduits, pores, cuts, or a modified surface architecture or topology to improve integration.

### Claim 12

A method of making a tissue graft comprising:
forming a modified surface, architecture, or shape of a donor tissue having a native matrix and/or viability to make the tissue graft, wherein the forming includes cutting the donor tissue with a fluid formed of a physiological buffered solution to maintain the native matrix and/or viability of the tissue at the modified surface.

### Claim 13 (depends on 12)

The method of claim 12, wherein cutting the donor tissue includes performing defined cuts with a sample or water cutter system controlled with a CNC system.

### Claim 14 (depends on 12)

The method of claim 12, wherein forming the modified tissue architecture while maintaining viability and native matrix includes visualizing and mapping the donor tissue and determining cutting paths using feedback from direct imaging and/or computational methods.

### Claim 15 (depends on 12)

The method of claim 12, wherein forming the modified tissue architecture includes forming a patient specific tissue graft by matching the shape, size, form, and architecture of the tissue to a patient anatomy and condition based on 2D or 3D images of an implant site and the patient anatomy and condition.

### Claim 16 (depends on 12)

The method of claim 12, wherein forming the modified tissue architecture includes:
forming pre-cut viable or non-viable chondral or osteochondral cores and complex, non-circular, or particulate osteochondral tissue shapes or
forming the architecture of the graft to create conduits, pores, or a modified surface architecture or topology to improve integration, with a bone or soft tissue graft.

### Claim 17 (depends on 12)

The method of claim 12, wherein forming the modified tissue architecture includes cutting the donor tissue with a particulate abrasive additive involving biocompatible materials.

### Claim 18 (depends on 12)

The method of claim 12, wherein forming the modified tissue architecture includes shaping or bending of a tissue graft in one or multiple axes to match a prescribe shape or curvature using controlled removal of slits, pores, or other prescribed regions of the tissue.

### Claim 19 (depends on 12)

The method of claim 12 further comprising shaping a tissue bed or removing autologous patient tissue in vivo during a surgical procedure, wherein shaping further includes:
preparing a surgical site in a proper geometry;
removing tissues in a site-specific manner, to remove necrotic tissue, tumors, burns, or fibrous tissue; and
removing foreign bodies or particles from native tissue.

### Claim 20

A method of forming a patient-specific tissue graft comprising:
obtaining a 3D image of a patient's targeted implant site and surrounding anatomy,
identifying and noting a boundary of the implant site,
creating a 3D model of a graft by utilizing the boundary of the implant site, a surface curvature, extrapolated from the patient's target implant site surrounding anatomy, and a depth, defined by a plane parallel to a plane normal to a point of curvature at the surface,
choosing donor tissue that has a location with a close approximation to the 3D model of the graft,
visualizing the donor tissue to determine a cutting path to shape or modify an architecture of the tissue,
identifying a cutting path with imaging technology and computational methods, and
cutting the graft out of the donor tissue utilizing a fluid cutting process that employs a fluid formed as a physiological buffered solution with computer numerical controls to cut the graft from the donor tissue along the cutting path.
